Cognitive Behavioral Treatment of Pediatric Trichotillomania
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00043563|
Recruitment Status : Completed
First Posted : August 12, 2002
Last Update Posted : December 16, 2015
|Condition or disease||Intervention/treatment||Phase|
|Trichotillomania||Behavioral: Cognitive-Behavior Therapy||Not Applicable|
TTM is a persistent impulse control disorder in which the individual acts on urges to pull out his or her own hair. Onset typically occurs by adolescence, and TTM is often associated with significant functional impairment and distress. CBT is a type of psychotherapy designed to change problematic behaviors and thinking. It includes self-monitoring of hair-pulling urges and homework assignments to practice the use of cognitive and behavioral strategies.
Participants are assigned randomly to receive either CBT or AC for 8 weeks. Participants assigned to CBT receive weekly 1-hour sessions of CBT for 8 weeks; participants assigned to AC receive 6 telephone contacts and 2 in-person sessions for 8 weeks. After 8 weeks, CBT participants who respond to treatment enter Phase II, which lasts an additional 8 weeks and includes 4 in-person maintenance sessions. AC participants who are still symptomatic after 8 weeks are offered CBT.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Cognitive Behavioral Treatment of Pediatric Trichotillomania|
|Study Start Date :||January 2001|
|Actual Primary Completion Date :||October 2004|
|Actual Study Completion Date :||October 2004|
- National Institute of Mental Health (NIMH) Trichotillomania Severity Scale [ Time Frame: 1 week ]Semi-structured interview about hair-pulling and related symptoms
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00043563
|United States, Pennsylvania|
|Center for the Treatment and Study of Anxiety|
|Philadelphia, Pennsylvania, United States, 19104|